Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
Ranpirnase in topical formulation is an antiviral drug being evaluated for the topical
treatment of anogenital warts. The aims of this study is to evaluate the efficacy and safety
of a topical formulation of ranpirnase in subjects with genital warts.